Bioelectronic Medicine: A New Field of Medicine

Kevin Tracey, MD, president and CEO of the Feinstein Institute for Medical Research, is an expert in the fields of medical innovation and bioelectronic medicine. Dr. Tracey explains bioelectronic medicine as, “the concept that makes it possible to design devices and specific computer chips, which interact with nerves in the patient's body to replace drugs.

It is a way to use electrical signals through computer chip-like devices and nerve stimulating electrodes that essentially replace drugs, such as Remicade and Enbrel, which people currently use to treat rheumatoid arthritis and inflammatory bowel disease.

This is the place where our current knowledge in molecular medicine, neurophysiology and biomedical engineering come together.”

We’ve created a short animated video to help illustrate this important new innovation:

Related Links:

Shaping the New Field of Bioelectronic Medicine

Donate to the Feinstein Institute for Medical Research.